Skip to content

Comparison of High-Flow Nasal Cannula and Face Mask Oxygen Therapy in Preventing Ipsilateral Cerebral Hyperperfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Randomized Controlled Trial

Comparison of High-Flow Nasal Cannula and Face Mask Oxygen Therapy in Preventing Ipsilateral Cerebral Hyperperfusion During Emergence From General Anesthesia in Patients Undergoing Carotid Endarterectomy: A Randomized Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105199
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-07-01
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Internal carotid artery stenosis

Interventions

High-Flow Nasal Oxygen Group (Group H):Administration of pure oxygen using a high-flow nasal oxygen (HFNO) device
Face Mask Oxygen Group (Group M):Administration of pure oxygen via face mask

Sponsors

Xuanwu Hospital Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. Patients undergoing elective internal carotid artery decortication in the Department of Neurosurgery of Xuanwu Hospital; 2. Age> = 18 years old, no restriction on gender 3. Patients with American Society of Anesthesiologists (ASA) grade I.~III.; 4. Good cognitive function and can cooperate with the implementation of the research protocol; 5. Unilateral carotid artery stenosis rate diagnosed by preoperative TCD >=50%; 6. Intraoperative TCD was used to monitor the cerebral blood flow in the middle cerebral artery; 7. Patients who voluntarily signed the "Informed Consent Form of Subjects".

Exclusion criteria

Exclusion criteria: 1. Previous history of nasopharyngeal malformation or surgery; 2. Patients with nasopharyngeal masses and vegetations or a recent history of nasopharyngeal bleeding; 3. Patients with acute nasopharyngeal inflammation; 4. Patients with respiratory failure or CO2 accumulation shown by preoperative arterial blood gas analysis (PaCO2>=45mmHg); 5. Other conditions that are not suitable for HFNO, such as complete upper airway obstruction, basilar skull fracture and nasal bone fracture.

Design outcomes

Primary

MeasureTime frame
Relative velocity of middle cerebral artery blood flow after 10 minutes of oxygen administration;

Secondary

MeasureTime frame
Relative velocity of middle cerebral artery blood flow;Blood pressure;Transcutaneous carbon dioxide monitoring value;Lowest oxygen saturation during oxygen administration;Incidence of subclinical respiratory depression;Incidence of oxygen-related adverse events;Incidence of hyperperfusion syndrome;

Countries

China

Contacts

Public ContactLei Zhao

Xuanwu Hospital of CCMU

zhaoalei@sina.com.cn+86 138 1103 5886

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jul 23, 2026